Cargando…
Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer
BACKGROUND: Approximately 10–20% of patients diagnosed with prostate cancer (PCa) evolve into castration-resistant prostate cancer (CRPC), while nearly 90% of patients with metastatic CRPC (mCRPC) exhibit osseous metastases (BM). These BM are intimately correlated with the stability of the tumour mi...
Autores principales: | Zhang, Qingfu, Zhang, Peng, Zhao, Zhongting, Wang, Jun, Zhang, Hepeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105558/ https://www.ncbi.nlm.nih.gov/pubmed/37070095 http://dx.doi.org/10.7717/peerj.15013 |
Ejemplares similares
-
Comparison of metastatic castration-resistant prostate cancer in bone with other sites: clinical characteristics, molecular features and immune status
por: Xu, Zhengquan, et al.
Publicado: (2021) -
Exploring the mechanism of Cassiae semen in regulating lipid metabolism through network pharmacology and experimental validation
por: Huang, Lili, et al.
Publicado: (2023) -
Identification of key genes and multiple molecular pathways of metastatic process in prostate cancer
por: Guo, Lihuang, et al.
Publicado: (2019) -
Differential expression profile of mRNAs, lncRNAs, and circRNAs reveals potential molecular mechanism in breast cancer
por: Li, Yuan, et al.
Publicado: (2022) -
Comprehensive analysis of fatty acid metabolism-related gene signatures for predicting prognosis in patients with prostate cancer
por: Wang, Hongbo, et al.
Publicado: (2023)